A Survey Coronavirus 2019 Vaccination of Cancer Patients in the Surgical Outpatient Department at Lopburi Cancer Hospital

Abstract

Background: The novel coronavirus 2019, a new strain of virus that has never been seen in humans, causes respiratory illnesses. It is therefore very important that all cancer patients receive the COVID-19 vaccination as soon as possible to reduce the mortality rate. Objective: This research aimed to explore the types of vaccines that cancer patients receive at Lopburi Cancer Hospital and to study the reasons for choosing the COVID-19 vaccine, as well as the relationship between receiving the COVID-19 vaccine with COVID-19 infection of cancer patients. Method: This was survey research. The sample size consisted of 885 cancer patients at Lopburi Cancer Hospital in June 2022. A simple random sampling method was used. Data were analyzed using descriptive statistics and Chi-square test. The questionnaire was used as a research tool. Results: Types of COVID-19 Vaccine that cancer patients chose to receive the most for the 1st dose was Sinovac vaccination, which was 42.1% of the patients. For the 2nd dose, 53.1% of the patients choseAstraZeneca vaccination. Pfizer vaccination was chosen for the 3rd and 4th doses, accounting for 28.8% and 3.3% of the patients, respectively. The reason for choosing the COVID-19 vaccine was that most cancer patients believed that vaccination would help prevent COVID-19 infection. In addition, the reason for not choosing the COVID-19 vaccine was that 87.7% of the patients feared that COVID-19 vaccination would result in death. Furthermore, 11.9% of cancer patients who had been vaccinated against COVID-19 were infected with coronavirus from family and in contact with other cancer patients who were receiving treatment at the same time. In addition, patients receiving COVID-19 vaccine were significantly associated with exposure to COVID-19. Conclusion: The maximum COVID-19 vaccine dosage given to cancer patients was 3 doses. The reason for choosing to receive the COVID-19 vaccine because it is believed that vaccines could help prevent COVID-19 infection.